BRONCHOGEN 20 MG

Dragon Pharma Bronchogen 20 mg – Synthetic Tetrapeptide for Respiratory Research

Dragon Pharma Bronchogen 20 mg is a synthetic tetrapeptide bioregulator with the amino acid sequence Ala-Glu-Asp-Leu (AEDL). As part of the well-characterized Khavinson peptide group, this compound has been the subject of experimental research focusing on lung tissue regeneration, DNA stabilization, and anti-inflammatory effects in respiratory models.

Each vial contains 20 mg of lyophilized Bronchogen in a 2 mL format, requiring reconstitution with bacteriostatic water before use. Bronchogen represents a targeted approach to studying pulmonary tissue repair mechanisms and the molecular pathways underlying respiratory health. For related research compounds, explore our peptides category and specifically SS-31 50 mg for mitochondrial function studies.

What Makes Bronchogen Valuable in Research?

Bronchogen belongs to a class of short-chain peptides known for their bioregulatory properties. The AEDL sequence has been investigated for its ability to influence gene expression patterns associated with tissue-specific repair mechanisms. In preclinical respiratory models, Bronchogen has demonstrated potential for supporting cellular regeneration and modulating inflammatory responses.

Researchers value Bronchogen for its targeted approach to pulmonary research. Its short sequence and defined mechanism of action make it a practical tool for investigating the molecular basis of lung tissue homeostasis and repair. For investigators exploring broader peptide-based interventions, Thymosin Alpha-1 offers complementary research avenues in immune modulation.

Current scientific literature on Khavinson peptides, including Bronchogen, can be accessed through the PubMed database, where researchers can review peer-reviewed studies on their biological activity and experimental applications.

Key Research Applications for Dragon Pharma Bronchogen

• ✔ Investigation of lung tissue regeneration mechanisms
• ✔ Evaluation of DNA stabilization in pulmonary cells
• ✔ Research on anti-inflammatory pathways in respiratory models
• ✔ Studies of peptide bioregulation in tissue repair
• ✔ Preclinical models of respiratory health and recovery

Product Details

Dosage & Usage Guidelines

Reconstitution Protocol

• ✔ Use sterile bacteriostatic water for injection
• ✔ Add appropriate volume to achieve desired concentration
• ✔ Swirl gently to dissolve – do not shake vigorously
• ✔ Store reconstituted solution at 2–8°C

Reconstitute the lyophilized powder using bacteriostatic water to a concentration suitable for your research protocol. The 20 mg format allows for flexible dosing across a range of experimental models. Always use aseptic technique during preparation to maintain peptide integrity.

Typical Research Parameters

In research settings, Bronchogen is typically administered via subcutaneous or intraperitoneal injection. Dosing schedules and concentrations vary widely depending on the experimental design, animal model, and specific research objectives.

• ✔ Commonly used in pulmonary tissue regeneration studies
• ✔ Often combined with histological and molecular analysis
• ✔ Used to investigate DNA stabilization and gene expression
• ✔ Research models include respiratory inflammation and repair

Factors to Consider in Research Protocols

• Short-chain peptide with specific bioregulatory properties
• Reconstitution stability is limited; prepare fresh solutions for each use
• Individual variation in response may be observed across subjects
• Storage conditions significantly impact peptide stability

Lab Testing & Batch Transparency

Lab status

COA pending release

Third-party analytical testing (COA) for Dragon Pharma Bronchogen 20 mg is currently not yet available. Batch-specific assay data, purity analysis, and verification documentation will be published once released.

Testing Status

Pending

COA Availability

Not yet published

Batch Verification

In progress

Update

Coming soon

Transparency note: Dragon Pharma publishes batch-specific lab reports once analytical testing is completed and verified.

Awaiting COA

Shipping & Product Authenticity

What to Expect

• ✔ Orders are processed after payment confirmation
• ✔ USA Domestic shipping is typically faster when local stock is selected
• ✔ International orders include tracking, though update frequency may vary by destination
• ✔ Multiple warehouses may result in separate shipments when applicable

For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.

Storage

Store the lyophilized powder at controlled room temperature (15–25°C) in a dry, dark place, away from direct light and moisture. The unopened vial should be kept in its original packaging to maintain stability.

After reconstitution, store the solution at 2–8°C and use within 14 days. Do not freeze. Discard any unused portion after the recommended storage period. Before use, inspect the solution and avoid use if it appears cloudy, discolored, or contains particulate matter, or if the vial or seal is compromised.

Keep out of reach of children. Follow proper handling and sterile injection practices during research use.

Proper storage conditions help maintain product stability and consistent performance across the product's shelf life.

Frequently Asked Questions